While some health plans move forward based on the value case alone, most require a clear and permissible way to pay for FIM before acting. Healthcare entities operate within defined regulatory and financial boundaries. Even interventions that make strong business sense can stall if they do not align with existing payment and policy frameworks. Those frameworks differ significantly by state, payer, and line of business, shaped by benefit rules, contractual arrangements, and the degree of flexibility plans have to invest in services beyond traditional medical care. Understanding these regulatory enablers is what turns interest into implementation.
For example, a health plan may choose to invest in MTM to help members with diabetes avoid complications. Whether the plan can treat all members with diabetes depends on the regulatory and payment context. In one line of business, policy may clearly allow meals to be covered as a benefit, making the decision straightforward. In another, the same plan may be limited to offering meals through a time-bound pilot, a voluntary supplemental benefit, or a contract tied to a narrow population, even when the clinical need is the same.
As a result, FIM is financed through several pathways. In some cases, plans or providers pay vendors directly for services delivered. Or, it is supported within capitated or value-based arrangements, where plans or risk-bearing providers have the flexibility to invest in services that reduce the total cost of care over time. In still other models, quality bonuses, performance incentives, or shared savings provide the financial space to support these programs.
The evidence for FIM opens the door; clear funding pathways determine whether plans will walk through it.
Explore the Three Pathways:
Medicaid ▶
Medicaid offers the clearest near-term payment pathways for FIM, but often the most operational complexity. Plans focus on whether services are allowable, how they are financed, and whether savings accrue within the same budget period.
In Medicare Advantage, plans are focused on total cost of care, quality performance, and Star Ratings. FIM competes with other supplemental benefits and quality investments, so marginal impact and timing are closely monitored.
Commercial markets are the least regulated and often the hardest place to make FIM work at scale. Plans focus on client demand, contract structure, and whether the organization has sufficient risk to justify the investment.
Important Legal and Regulatory Notice and Disclaimer
FIM initiatives operate within complex and evolving federal and state legal and regulatory frameworks that vary significantly by line of business (e.g., Medicaid, Medicare Advantage, and commercial coverage), state policy, contracting structure, and program design. The pathways described in this chapter are illustrative and should not be interpreted as legal guidance or assurances of permissibility, compliance, or reimbursement.
Health plans, providers, and other stakeholders should consult their own legal, compliance, and regulatory teams — and, where appropriate, state or federal agencies — before designing, implementing, or scaling any FIM initiative to ensure alignment with applicable laws, regulations, contractual requirements, and program‑specific guidance.
This toolkit is intended for informational purposes only and does not constitute legal, regulatory, or compliance advice.
◀ The FIM Value Proposition
FIM in Medicaid ▶